Cargando…
Clinicopathologic significance of protein lysine methyltransferases in cancer
Protein lysine methyltransferases (PKMTs) constitute a large family of approximately 50 chromatin modifiers that mono-, di- and/or tri-methylate lysine residues on histone and non-histone substrates. With the advent of The Cancer Genome Atlas, it became apparent that this family of chromatin modifie...
Autores principales: | Vougiouklakis, Theodore, Bernard, Benjamin J., Nigam, Nupur, Burkitt, Kyunghee, Nakamura, Yusuke, Saloura, Vassiliki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557092/ https://www.ncbi.nlm.nih.gov/pubmed/33050946 http://dx.doi.org/10.1186/s13148-020-00897-3 |
Ejemplares similares
-
The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2018) -
SMYD3: a regulator of epigenetic and signaling pathways in cancer
por: Bernard, Benjamin J., et al.
Publicado: (2021) -
Protein methyltransferases and demethylases dictate CD8+ T-cell exclusion in squamous cell carcinoma of the head and neck
por: Vougiouklakis, Theodore, et al.
Publicado: (2017) -
WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2020) -
Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer
por: Burkitt, Kyunghee, et al.
Publicado: (2021)